FDA Inspection 1317040 — Hemagen Diagnostics Inc

Hemagen Diagnostics Inc — FEI 1181055

The FDA completed an inspection of Hemagen Diagnostics Inc on May 14, 2026 in Baltimore, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 14, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Baltimore, MD (United States)

Citations

IDCFRDescription
23044ISO 13485:2016 Clause 4.2.5Procedures for control of records not documented
23142ISO 13485:2016 Clause 7.4.1Supplier performance not monitored
23255ISO 13485:2016 Clause 8.5.2Corrective action not taken
23258ISO 13485:2016 Clause 8.5.2Corrective action procedures not documented

Need the full FDA record for Hemagen Diagnostics Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.